OABI
NASDAQ · Life Sciences Tools & Services
Omniab Inc
$2.48
+0.02 (+0.81%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+121.0% upside
Low Target
$3.95
Average Target
$5.48
High Target
$7.31
Current Price
$2.48
Current
$2.48
$2.48
Target
$5.48
$5.48
$3.95
$5.48 avg
$7.31
Scenario Analysis
Bear Case
$3.95
59.3%
Low target
Base Case
$5.48
+121.0%
Avg target
Bull Case
$7.31
+194.8%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$2.79
-11.1% from high
52-Week Low
$1.30
+90.8% from low
Target vs 52W High
$5.48
+96.4% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 85% | $369.21 | -29.5% |
| DHR | Strong Buy | 30 | 90% | $158.11 | -20.1% |
| WAT | Buy | 28 | 57% | $189.60 | -50.0% |
| A | Strong Buy | 28 | 79% | $64.69 | -50.5% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -59.9% |
| ILMN | Buy | 28 | 61% | $169.36 | -10.2% |
| MTD | Hold | 20 | 50% | $170.43 | -87.0% |
| WST | Strong Buy | 22 | 82% | $136.24 | -62.7% |